Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis

Main Article Content

Hatice Kayabas
Fatma Devran Bildircin
Bahattin Avci
Pervin Karli
Ayse Zehra Ozdemir
Tayfun Alper

Abstract

Aim: To determine the efficiency of serum amyloid-A (SAA) in predicting preterm premature rupture of membrane (PPROM) and chorioamnionitis in risky cases. Study Design: The study consists of 20 women 26-37 weeks of pregnancy who had PPROM and 20 pregnant women without water breaks. Levels of SAA were determined in maternal venous and umbilical cord blood. Results: SAA values in cord blood and venous blood of mothers with PPROM were higher than in the control group (p0,05). SAA values in the patients with clinical chorioamnionitis (n=9) were significantly higher (p0,05) than both PPROM patients without chorioamnionitis (n=11) and the control group (n=20). Conclusion: In women at risk for PPROM in whom diagnosis cannot be established, blood SSA levels can be used as a marker. Increased SAA values in pregnant women with PPROM who were conservatively treated were considered a marker for chorioamnionitis.

Downloads

Download data is not yet available.

Article Details

How to Cite
Kayabas, H., Devran Bildircin, F., Avci, B., Karli, P., Zehra Ozdemir, A., & Alper, T. (2021). Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis . Annals of Medical Research, 26(12), 2802–2806. Retrieved from http://annalsmedres.org/index.php/aomr/article/view/1911
Section
Original Articles